ID   KC1A_HUMAN              Reviewed;         337 AA.
AC   P48729; D3DQG0; D3DQG1; Q4JJA0; Q5U046; Q5U047; Q6FGA2; Q71TU5;
AC   Q96HD2; Q9UDK3;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-MAY-2003, sequence version 2.
DT   15-MAR-2017, entry version 181.
DE   RecName: Full=Casein kinase I isoform alpha;
DE            Short=CKI-alpha;
DE            EC=2.7.11.1;
DE   AltName: Full=CK1;
GN   Name=CSNK1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8050587; DOI=10.1016/0014-5793(94)00679-2;
RA   Tapia C., Featherstone T., Gomez C., Taillon-Miller P., Allende C.C.,
RA   Allende J.E.;
RT   "Cloning and chromosomal localization of the gene coding for human
RT   protein kinase CK1.";
RL   FEBS Lett. 349:307-312(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7797465; DOI=10.1074/jbc.270.25.14875;
RA   Fish K.J., Cegielska A., Getman M.E., Landes G.M., Virshup D.M.;
RT   "Isolation and characterization of human casein kinase I epsilon
RT   (CKI), a novel member of the CKI gene family.";
RL   J. Biol. Chem. 270:14875-14883(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Lin L., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z.,
RA   Liang M., Huang B., Li H., Yang S.;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 65-83; 111-152 AND 179-204, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=1409656; DOI=10.1073/pnas.89.20.9454;
RA   Brockman J.L., Gross S.D., Sussman M.R., Anderson R.A.;
RT   "Cell cycle-dependent localization of casein kinase I to mitotic
RT   spindles.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9454-9458(1992).
RN   [12]
RP   ROLE IN WNT SIGNALING.
RX   PubMed=11955436; DOI=10.1016/S0092-8674(02)00685-2;
RA   Liu C., Li Y., Semenov M., Han C., Baeg G.-H., Tan Y., Zhang Z.,
RA   Lin X., He X.;
RT   "Control of beta-catenin phosphorylation/degradation by a dual-kinase
RT   mechanism.";
RL   Cell 108:837-847(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   FUNCTION, INTERACTION WITH TUT1, AND SUBCELLULAR LOCATION.
RX   PubMed=18305108; DOI=10.1074/jbc.M800656200;
RA   Gonzales M.L., Mellman D.L., Anderson R.A.;
RT   "CKIalpha is associated with and phosphorylates star-PAP and is also
RT   required for expression of select star-PAP target messenger RNAs.";
RL   J. Biol. Chem. 283:12665-12673(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-321 (ISOFORM 3), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [22]
RP   FUNCTION, INTERACTION WITH FAM83H, AND SUBCELLULAR LOCATION.
RX   PubMed=23902688; DOI=10.1242/jcs.129684;
RA   Kuga T., Kume H., Kawasaki N., Sato M., Adachi J., Shiromizu T.,
RA   Hoshino I., Nishimori T., Matsubara H., Tomonaga T.;
RT   "A novel mechanism of keratin cytoskeleton organization through casein
RT   kinase Ialpha and FAM83H in colorectal cancer.";
RL   J. Cell Sci. 126:4721-4731(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-297.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. It can phosphorylate a large number of proteins.
CC       Participates in Wnt signaling. Phosphorylates CTNNB1 at 'Ser-45'.
CC       May phosphorylate PER1 and PER2. May play a role in segregating
CC       chromosomes during mitosis (PubMed:11955436, PubMed:1409656,
CC       PubMed:18305108). May play a role in keratin cytoskeleton
CC       disassembly and thereby, it may regulate epithelial cell migration
CC       (PubMed:23902688). {ECO:0000269|PubMed:11955436,
CC       ECO:0000269|PubMed:1409656, ECO:0000269|PubMed:18305108,
CC       ECO:0000269|PubMed:23902688}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Monomer. Interacts with the Axin complex. Interacts with
CC       TUT1, leading to TUT1 phosphorylation. Interacts with FAM83H;
CC       recruits CSNK1A1 to keratin filaments (PubMed:23902688).
CC       {ECO:0000269|PubMed:18305108, ECO:0000269|PubMed:23902688}.
CC   -!- INTERACTION:
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-10106282, EBI-5323863;
CC       Q00987:MDM2; NbExp=3; IntAct=EBI-1383726, EBI-389668;
CC       O15151:MDM4; NbExp=2; IntAct=EBI-1383726, EBI-398437;
CC       Q13546:RIPK1; NbExp=5; IntAct=EBI-1383726, EBI-358507;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1409656}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:1409656}. Chromosome, centromere, kinetochore
CC       {ECO:0000269|PubMed:1409656}. Nucleus speckle
CC       {ECO:0000303|PubMed:18305108}. Note=Localizes to the centrosome in
CC       interphase cells, and to kinetochore fibers during mitosis. Also
CC       recruited to the keratin cytoskeleton (PubMed:23902688).
CC       {ECO:0000269|PubMed:1409656, ECO:0000269|PubMed:23902688}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P48729-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48729-2; Sequence=VSP_035455;
CC         Note=Contains a phosphoserine at position 156.
CC         {ECO:0000244|PubMed:18691976};
CC       Name=3;
CC         IsoId=P48729-3; Sequence=VSP_055131;
CC         Note=Contains a phosphothreonine at position 321.
CC         {ECO:0000244|PubMed:20068231};
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CSNK1A1ID40168ch5q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X80693; CAA56710.1; -; mRNA.
DR   EMBL; L37042; AAC41760.1; -; mRNA.
DR   EMBL; AF218004; AAG17246.1; -; mRNA.
DR   EMBL; AK294942; BAG58018.1; -; mRNA.
DR   EMBL; CR542206; CAG47002.1; -; mRNA.
DR   EMBL; BT019829; AAV38632.1; -; mRNA.
DR   EMBL; BT019830; AAV38633.1; -; mRNA.
DR   EMBL; DQ082865; AAY84562.1; -; mRNA.
DR   EMBL; AC021078; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61767.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61769.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61773.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61774.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61776.1; -; Genomic_DNA.
DR   EMBL; BC008717; AAH08717.1; -; mRNA.
DR   CCDS; CCDS47303.1; -. [P48729-1]
DR   CCDS; CCDS47304.1; -. [P48729-2]
DR   CCDS; CCDS64291.1; -. [P48729-3]
DR   PIR; A57011; A57011.
DR   PIR; S46254; S46254.
DR   RefSeq; NP_001020276.1; NM_001025105.2. [P48729-2]
DR   RefSeq; NP_001258670.1; NM_001271741.1. [P48729-3]
DR   RefSeq; NP_001258671.1; NM_001271742.1.
DR   RefSeq; NP_001883.4; NM_001892.5. [P48729-1]
DR   UniGene; Hs.529862; -.
DR   UniGene; Hs.712555; -.
DR   PDB; 5FQD; X-ray; 2.45 A; C/F=1-337.
DR   PDBsum; 5FQD; -.
DR   ProteinModelPortal; P48729; -.
DR   SMR; P48729; -.
DR   BioGrid; 107836; 107.
DR   DIP; DIP-40367N; -.
DR   IntAct; P48729; 59.
DR   MINT; MINT-193806; -.
DR   BindingDB; P48729; -.
DR   ChEMBL; CHEMBL2793; -.
DR   GuidetoPHARMACOLOGY; 1995; -.
DR   iPTMnet; P48729; -.
DR   PhosphoSitePlus; P48729; -.
DR   SwissPalm; P48729; -.
DR   BioMuta; CSNK1A1; -.
DR   DMDM; 31077177; -.
DR   EPD; P48729; -.
DR   MaxQB; P48729; -.
DR   PeptideAtlas; P48729; -.
DR   PRIDE; P48729; -.
DR   TopDownProteomics; P48729-1; -. [P48729-1]
DR   DNASU; 1452; -.
DR   Ensembl; ENST00000261798; ENSP00000261798; ENSG00000113712. [P48729-3]
DR   Ensembl; ENST00000377843; ENSP00000367074; ENSG00000113712. [P48729-1]
DR   Ensembl; ENST00000515768; ENSP00000421689; ENSG00000113712. [P48729-2]
DR   GeneID; 1452; -.
DR   KEGG; hsa:1452; -.
DR   UCSC; uc003lqw.3; human. [P48729-1]
DR   CTD; 1452; -.
DR   DisGeNET; 1452; -.
DR   GeneCards; CSNK1A1; -.
DR   HGNC; HGNC:2451; CSNK1A1.
DR   HPA; CAB016680; -.
DR   HPA; HPA051334; -.
DR   MIM; 600505; gene.
DR   neXtProt; NX_P48729; -.
DR   OpenTargets; ENSG00000113712; -.
DR   PharmGKB; PA26951; -.
DR   GeneTree; ENSGT00760000119040; -.
DR   HOGENOM; HOG000182055; -.
DR   HOVERGEN; HBG000176; -.
DR   InParanoid; P48729; -.
DR   KO; K08957; -.
DR   OMA; HIGYRED; -.
DR   OrthoDB; EOG091G0AFG; -.
DR   PhylomeDB; P48729; -.
DR   TreeFam; TF354246; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-196299; Beta-catenin phosphorylation cascade.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-HSA-5339716; Misspliced GSK3beta mutants stabilize beta-catenin.
DR   Reactome; R-HSA-5358747; S33 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358749; S37 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358751; S45 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5358752; T41 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; R-HSA-5467337; APC truncation mutants have impaired AXIN binding.
DR   Reactome; R-HSA-5467340; AXIN missense mutants destabilize the destruction complex.
DR   Reactome; R-HSA-5467348; Truncations of AMER1 destabilize the destruction complex.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5635838; Activation of SMO.
DR   SignaLink; P48729; -.
DR   SIGNOR; P48729; -.
DR   ChiTaRS; CSNK1A1; human.
DR   GeneWiki; Casein_kinase_1,_alpha_1; -.
DR   GenomeRNAi; 1452; -.
DR   PRO; PR:P48729; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113712; -.
DR   CleanEx; HS_CSNK1A1; -.
DR   ExpressionAtlas; P48729; baseline and differential.
DR   Genevisible; P48729; HS.
DR   GO; GO:0030877; C:beta-catenin destruction complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005929; C:cilium; TAS:Reactome.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:1904885; P:beta-catenin destruction complex assembly; TAS:Reactome.
DR   GO; GO:1904886; P:beta-catenin destruction complex disassembly; TAS:Reactome.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0007030; P:Golgi organization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0045104; P:intermediate filament cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IC:ParkinsonsUK-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006909; P:phagocytosis; IBA:GO_Central.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   GO; GO:1904424; P:regulation of GTP binding; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0016055; P:Wnt signaling pathway; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell cycle; Cell division; Centromere; Chromosome; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Kinase;
KW   Kinetochore; Mitosis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Wnt signaling pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    337       Casein kinase I isoform alpha.
FT                                /FTId=PRO_0000192822.
FT   DOMAIN       17    285       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      23     31       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      46     46       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       8      8       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     152    152       K -> KCLESPVGKRKRSMTVSTSQDPSFSGLNQ (in
FT                                isoform 2). {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_035455.
FT   VAR_SEQ     324    335       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15498874}.
FT                                /FTId=VSP_055131.
FT   VARIANT     297    297       D -> H (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042073.
FT   CONFLICT     45     45       V -> L (in Ref. 1; CAA56710).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       P -> T (in Ref. 6; AAV38633).
FT                                {ECO:0000305}.
FT   CONFLICT    122    122       S -> A (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    129    129       T -> TK (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       Q -> K (in Ref. 10; AAH08717).
FT                                {ECO:0000305}.
FT   CONFLICT    250    250       K -> E (in Ref. 7; AAY84562).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       T -> S (in Ref. 1; CAA56710 and 6;
FT                                AAV38632/AAV38633). {ECO:0000305}.
FT   TURN         14     16       {ECO:0000244|PDB:5FQD}.
FT   STRAND       17     24       {ECO:0000244|PDB:5FQD}.
FT   STRAND       27     36       {ECO:0000244|PDB:5FQD}.
FT   TURN         37     39       {ECO:0000244|PDB:5FQD}.
FT   STRAND       42     49       {ECO:0000244|PDB:5FQD}.
FT   HELIX        57     67       {ECO:0000244|PDB:5FQD}.
FT   STRAND       76     82       {ECO:0000244|PDB:5FQD}.
FT   STRAND       85     91       {ECO:0000244|PDB:5FQD}.
FT   HELIX        97    103       {ECO:0000244|PDB:5FQD}.
FT   HELIX       110    129       {ECO:0000244|PDB:5FQD}.
FT   HELIX       139    141       {ECO:0000244|PDB:5FQD}.
FT   STRAND      142    144       {ECO:0000244|PDB:5FQD}.
FT   HELIX       147    149       {ECO:0000244|PDB:5FQD}.
FT   STRAND      153    155       {ECO:0000244|PDB:5FQD}.
FT   TURN        167    169       {ECO:0000244|PDB:5FQD}.
FT   TURN        185    187       {ECO:0000244|PDB:5FQD}.
FT   HELIX       190    193       {ECO:0000244|PDB:5FQD}.
FT   HELIX       200    215       {ECO:0000244|PDB:5FQD}.
FT   STRAND      216    218       {ECO:0000244|PDB:5FQD}.
FT   TURN        220    223       {ECO:0000244|PDB:5FQD}.
FT   HELIX       229    242       {ECO:0000244|PDB:5FQD}.
FT   HELIX       245    248       {ECO:0000244|PDB:5FQD}.
FT   TURN        249    251       {ECO:0000244|PDB:5FQD}.
FT   HELIX       254    264       {ECO:0000244|PDB:5FQD}.
FT   HELIX       274    287       {ECO:0000244|PDB:5FQD}.
FT   HELIX       297    301       {ECO:0000244|PDB:5FQD}.
SQ   SEQUENCE   337 AA;  38915 MW;  1B2085AE33CAFAC2 CRC64;
     MASSSGSKAE FIVGGKYKLV RKIGSGSFGD IYLAINITNG EEVAVKLESQ KARHPQLLYE
     SKLYKILQGG VGIPHIRWYG QEKDYNVLVM DLLGPSLEDL FNFCSRRFTM KTVLMLADQM
     ISRIEYVHTK NFIHRDIKPD NFLMGIGRHC NKLFLIDFGL AKKYRDNRTR QHIPYREDKN
     LTGTARYASI NAHLGIEQSR RDDMESLGYV LMYFNRTSLP WQGLKAATKK QKYEKISEKK
     MSTPVEVLCK GFPAEFAMYL NYCRGLRFEE APDYMYLRQL FRILFRTLNH QYDYTFDWTM
     LKQKAAQQAA SSSGQGQQAQ TPTGKQTDKT KSNMKGF
//
